LoginRegister
    Zealand Pharma to acquire insulin pump maker Valeritas for USD 23 millionZealand Pharma to acquire insulin pump maker Valeritas for USD 23 million
    Roche Alzheimers disease drug fails to meet primary goalRoche Alzheimers disease drug fails to meet primary goal
    Nestle invests $200 million more in Aimmune after peanut allergy drug approvalNestle invests $200 million more in Aimmune after peanut allergy drug approval
    JB Chemicals Gujarat unit passes USFDA inspection with one observationJB Chemicals Gujarat unit passes USFDA inspection with one observation
    Coronavirus in China cause of concern for Indian Pharma SectorCoronavirus in China cause of concern for Indian Pharma Sector
    Cipla acquires 4 key brands from Wanbury for up to Rs 89 croreCipla acquires 4 key brands from Wanbury for up to Rs 89 crore
    Cipla acquires 4 nutrition products from Wanbury for Rs 89 croreCipla acquires 4 nutrition products from Wanbury for Rs 89 crore
    Bevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademarkBevetex Vs Bevatas: Delhi HC junks Sun Pharma arm plea against Intas Pharma over trademark
    FDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: GovernmentFDI in drugs and pharma sector rose to Rs 2065 crore in April-Sept FY20: Government
    Dr Reddys launches generic version of Syprine in USDr Reddys launches generic version of Syprine in US
    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 croreReligare Enterprises to divest stake in arm to Kedaara for Rs 200 crore
    Pfizer Oncology biosimilar Ruxience gets positive opinion from CHMPPfizer Oncology biosimilar Ruxience gets positive opinion from CHMP
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X